
    
      The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of
      GX-E2 when given as single dose (GX-E2 8 ug/kg) to healthy male subjects. Additionally,
      Immunogenecity will be evaluated to investigate antibody production.
    
  